期刊文献+

卵巢原发性恶性淋巴瘤7例临床分析 被引量:2

Clinical Analysis of 7 Cases with Malignant Lymphoma of Primary Ovary
下载PDF
导出
摘要 目的 :探讨卵巢原发性恶性淋巴瘤的临床特点和治疗方法。方法 :回顾性分析 1980年 1月 -2 0 0 0年 12月收治的 7例卵巢原发性淋巴瘤 ,均行手术切除和CHOP化疗 ,2例配合盆腔外照射治疗。结果 :中位年龄 30岁 ,首发症状为盆腹腔肿块 ,1例合并不典型B类症状 ,病理类型全部为NHL ,来源于B细胞 ,中度恶性 ,中位生存期 37个月。结论 :已婚育的年轻妇女为卵巢原发性恶性淋巴瘤的高发年龄。治疗宜采用以手术为主的综合治疗 ,疗效优于卵巢以外的NHL。 Objective To investigate the clinical features and treatment of malignant lymphoma of primary ovary.Methods Form January 1980 to December 2000,seven patients with malignant lymphoma of primary ovary were treated,and the therapies contained primary cytoreductive surgery as well as chemotherapy (CHOP),and pelvic external radiotherapy for 2 cases.The clinical data were analyzed retrospectively.Results Their medial age was 30 years.The incipient complaint was neoplasmata.Only one case had typeless B symptom(weight descended>10%).All cases were diagnosed as NHL by histopathology examination,come from B cell,mid grade malignancy.Mid survival time was 37 months for seven patients.Conclusions It is more in danger of the stage for young women married and after parturition to suffer from malignant lymphoma of primary ovary.It is necessary for these patients to undergo operation and combined therapies.The survival time of ovarian cases is longer than other NHL.
出处 《肿瘤防治杂志》 2003年第11期1198-1199,共2页 China Journal of Cancer Prevention and Treatment
关键词 卵巢肿瘤 原发性 淋巴瘤/诊断 治疗 ovarian tumor,primary lymphoma/diagnosis therapy
  • 相关文献

参考文献2

二级参考文献1

共引文献3242

同被引文献16

  • 1白萍,孙建衡.生殖系统原发性恶性淋巴瘤15例临床分析[J].中华妇产科杂志,1995,30(10):614-617. 被引量:19
  • 2李洪君,张蓉,李淑敏,李晓光,吴令英.卵巢非霍奇金淋巴瘤11例临床分析[J].临床肿瘤学杂志,2007,12(1):30-32. 被引量:4
  • 3郭琤琤,黄岩,翟林柱,Saroj Niraula,叶昇,王树森,黄慧强,孙晓非,徐瑞华,夏忠军,管忠震,林桐榆.卵巢原发淋巴瘤的临床病理特征及相关文献复习[J].临床肿瘤学杂志,2007,12(7):494-497. 被引量:9
  • 4Dimopoulos MA, Daliani D, Pugh W, et al. Primary ovarian nonHodgkin's lymphoma: outeome after treatment with combinationchemotherapy [J] . Gyneeol Oneol, 1997, 64 (3):446 450.
  • 5Tang Y,Nakada MT, Kesavan P, et al. Extracellula rmatrix metalloproteinases inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases [J]. Cancer Res,2005,65 (8):3193 3199.
  • 6Koyama Y, Kaneko K, Akazawa K, et al. Vascular endothelialgr owth factor C and vascular endothelial growth factor D messenger RNA expression in breast cancer association with lymph nodemetastasis[ J ]. Clin Breast Cancer, 2003, 4 (5) : 354 360.
  • 7Monterroso V, Jaffe ES,Merino MJ, et al . Malignant lymphomas involving the ovary [ J ]. Am J Surg Pathol, 1993, 17 ( 2 ) : 154170.
  • 8Iyengar P, Ismiil N. Deodhare S1 Precursor B2eell lymphoblasticlymphoma of the ovaries : an immunohistochemical study and review of the literature [J]. IntJ Gynecol Pathol, 2004, 23 (2) : 193-197.
  • 9Fox H, Langley FA, Govan ADT, et al.Malignant Lymp homapresenting as an ovarian tumor :a Clinicopat hological analysis of 34 cases[J] .Br J Obstet Gynecol , 1988 ,95:386.
  • 10Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of astandard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin' s lymphoma[J]. N Engl JMed , 1993,328: 1002-1006.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部